H1-3
Basic information
Region (hg38): 6:26234211-26234987
Previous symbols: [ "H1F3", "HIST1H1D" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the H1-3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 44 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 7 | 0 |
Variants in H1-3
This is a list of pathogenic ClinVar variants found in the H1-3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-26234281-G-C | not specified | Uncertain significance (May 06, 2024) | ||
6-26234288-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
6-26234293-T-C | not specified | Uncertain significance (May 11, 2022) | ||
6-26234303-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
6-26234327-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
6-26234332-G-C | not specified | Uncertain significance (Sep 27, 2022) | ||
6-26234350-G-A | not specified | Likely benign (Oct 27, 2022) | ||
6-26234356-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
6-26234357-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
6-26234377-GCTT-G | Likely benign (Apr 01, 2023) | |||
6-26234403-C-G | not specified | Uncertain significance (Aug 11, 2022) | ||
6-26234422-A-G | not specified | Uncertain significance (Nov 21, 2022) | ||
6-26234437-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
6-26234444-T-C | not specified | Likely benign (May 24, 2023) | ||
6-26234455-T-C | not specified | Uncertain significance (Jul 19, 2023) | ||
6-26234464-T-G | not specified | Uncertain significance (Jun 02, 2023) | ||
6-26234476-T-C | not specified | Uncertain significance (May 23, 2023) | ||
6-26234497-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
6-26234509-A-G | not specified | Likely benign (Feb 01, 2023) | ||
6-26234537-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
6-26234549-G-A | not specified | Uncertain significance (Jul 31, 2023) | ||
6-26234563-G-C | not specified | Uncertain significance (May 25, 2022) | ||
6-26234564-C-T | not specified | Uncertain significance (Jun 22, 2023) | ||
6-26234570-T-G | not specified | Uncertain significance (Nov 18, 2023) | ||
6-26234578-G-A | not specified | Uncertain significance (Jan 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
H1-3 | protein_coding | protein_coding | ENST00000244534 | 1 | 777 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.156 | 0.650 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -8.06 | 368 | 120 | 3.07 | 0.00000527 | 1399 |
Missense in Polyphen | 67 | 27.272 | 2.4567 | 322 | ||
Synonymous | -12.3 | 160 | 49.6 | 3.23 | 0.00000225 | 487 |
Loss of Function | 0.726 | 1 | 2.15 | 0.466 | 8.77e-8 | 54 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity). {ECO:0000250}.;
- Pathway
- Formation of Senescence-Associated Heterochromatin Foci (SAHF);DNA Damage/Telomere Stress Induced Senescence;Cellular Senescence;Cellular responses to stress;Activation of DNA fragmentation factor;Apoptosis induced DNA fragmentation;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Cellular responses to external stimuli
(Consensus)
Recessive Scores
- pRec
- 0.189
Intolerance Scores
- loftool
- 0.456
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 28.11
Haploinsufficiency Scores
- pHI
- 0.239
- hipred
- hipred_score
- ghis
- 0.418
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.983
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hist1h1d
- Phenotype
- endocrine/exocrine gland phenotype; growth/size/body region phenotype; immune system phenotype; embryo phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;nucleosome assembly;regulation of transcription, DNA-templated;nucleosome positioning;chromosome condensation;negative regulation of chromatin silencing;negative regulation of DNA recombination;histone H3-K4 trimethylation;histone H3-K27 trimethylation
- Cellular component
- nucleosome;nuclear chromatin;nucleus;nuclear euchromatin
- Molecular function
- double-stranded DNA binding;RNA binding;protein binding;chromatin DNA binding;nucleosomal DNA binding